September 26, 2016 2:56 PM ET

Biotechnology

Company Overview of Catalyst Biosciences, Inc.

Key Executives for Catalyst Biosciences, Inc.

NameBoard RelationshipsTitleAge
Nassim Usman Ph.D.26 RelationshipsChief Executive Officer, President and Director56
Charles S. Craik Ph.D.45 RelationshipsCo-Founder and Chairman of Scientific Advisory Board--
Jack Nguyen Ph.D.No RelationshipsCo-Founder--
Fletcher Payne No RelationshipsChief Financial Officer53
Howard Levy M.B.B.Ch., Ph.D., M.M.M.5 RelationshipsChief Medical Officer62

Catalyst Biosciences, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Harold E. Selick Ph.D. 56 RelationshipsThreshold Pharmaceuticals Inc.62
Nassim Usman Ph.D. 26 RelationshipsCatalyst Biosciences, Inc.56
Charles S. Craik Ph.D. 45 RelationshipsCatalyst Biosciences, Inc.--
Augustine J. Lawlor 131 RelationshipsGITR Inc.60
John P. Richard Ph.D., MBA 94 RelationshipsAgennix AG59
View All Board Members

Catalyst Biosciences, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Augustine J. Lawlor131 Relationships3 Executives
Compensation Committee Ph.D.Harold E. Selick56 Relationships3 Executives
Nominating Committee Ph.D., MBAJohn P. Richard94 Relationships3 Executives
Corporate Governance Committee Ph.D., MBAJohn P. Richard94 Relationships3 Executives
Advisory Board Ph.D.Charles S. Craik45 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$413.3K
413.3K
383.9K
Bonus$169.4K
169.4K
263.7K
Total Short Term Compensation
Not meaningful
Total Value of Options$582.7K
582.7K
33.7M
Compensation as of Fiscal Year 2015
Catalyst Biosciences, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

GlycoMimetics, Inc. Announces the Intention of Franklin H. Top to Resign as Directors Effective January 1, 2017
September 23, 2016 1:31 PM ET
Symic Bio Appoints Thomas N. Wight to Scientific Advisory Board
September 23, 2016 12:01 PM ET
Momenta Pharmaceuticals Inc. Appoints Corey N. Fishman to its Board of Directors
September 23, 2016 12:00 PM ET
uniQure N.V. Announces Management and Board Changes
September 22, 2016 8:18 PM ET
Ligand Pharmaceuticals Incorporated Announces Change of Principal Accounting Officer
September 22, 2016 8:06 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Catalyst Biosciences, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.